Tuesday, May 14, 2024
Tuesday, May 14, 2024
HomeTagsTlx250-cdx

Tag: tlx250-cdx

-Advertisement-

Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer to be Introduced at SABCS

MELBOURNE, Australia, Nov. 30, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) immediately advises that the finished Phase II OPALESCENCE investigator-initiated trial...

Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC

MELBOURNE, Australia, June 26, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reveals more information of the positive arise from...
-Advertisement-

Must read

-Advertisement-